It is challenging to navigate biosimilars regulation and the payer landscape, provide real world evidence to physicians, and compete for the right sites and patients. IQVIA an help you overcome these obstacles and make better decisions throughout your study's lifecycle using a customized approach backed by expertise in more than 13 therapeutic areas.
It starts when you leverage the power of the IQVIA CORE. This is how we use unparalleled data, transformative technology, advanced analytics, and scientific expertise to help achieve study goals and bring biosimilar drugs to market faster.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Navigate complex regulatory requirements with expert insights and bring transparency, efficiency and predictability to your regulatory affairs strategy.
Strengthen your portfolio by making more informed decisions and fewer assumptions, and prepare for the impact of new research discoveries and events.
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.